Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Luhn · SciRah

Researcher profile · Semantic Scholar

P. Luhn

Share profile

P. Luhn — researcher profile on SciRah

h-index: 16
Works: 49
Citations: 918

Most-cited papers

Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts
V. Sahasrabuddhe, P. Luhn, N. Wentzensen
2011Future Microbiology149 citations Open access
Semantic Scholar
The role of co-factors in the progression from human papillomavirus infection to cervical cancer
P. Luhn, J. Walker, M. Schiffman, R. Zuna +8 more
2012Gynecologic Oncology141 citations Open access
Semantic Scholar
Circulating adipokine levels and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
P. Luhn, C. Dallal, J. Weiss, A. Black +6 more
2013Cancer Epidemiology, Biomarkers and Prevention79 citations Open access
Semantic Scholar
Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer
Megan A. Clarke, P. Luhn, J. Gage, C. Bodelon +9 more
2017International Journal of Cancer71 citations Open access
Semantic Scholar
Discovery and validation of methylation markers for endometrial cancer
N. Wentzensen, Jamie N. Bakkum-Gamez, J. Killian, Joshua N. Sampson +16 more
2014International Journal of Cancer70 citations Open access
Semantic Scholar
Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men.
Lauren M. Schwartz, P. Castle, Stephen Follansbee, S. Borgonovo +8 more
2013Journal of Infectious Diseases62 citations Open access
Semantic Scholar
Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma
A. Drakaki, P. Dhillon, H. Wakelee, S. Chui +7 more
2020Oncoimmunology47 citations Open access
Semantic Scholar
PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors
Hannah P. Yang, A. Meeker, R. Guido, M. Gunter +5 more
2015Cancer Causes and Control39 citations Open access
Semantic Scholar
14-3-3 checkpoint regulatory proteins interact specifically with DNA repair protein human exonuclease 1 (hEXO1) via a semi-conserved motif
S. D. Andersen, G. Keijzers, E. Rampakakis, K. Engels +10 more
2012DNA Repair36 citations Open access
Semantic Scholar
CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation prevalence and more altered genomic landscape
Nayan Chaudhary, A. Chibly, A. Collier, J. Martinalbo +5 more
2024npj Breast Cancer32 citations Open access
Semantic Scholar
Validation of diagnosis codes to identify side of colon in an electronic health record registry
P. Luhn, D. Kuk, G. Carrigan, N. Nussbaum +6 more
2017BMC Medical Research Methodology29 citations Open access
Semantic Scholar
Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program
R. Morley, Alison Cardenas, P. Hawkins, Yasuyo Suzuki +9 more
2015PLoS ONE25 citations Open access
Semantic Scholar
Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results
P. Luhn, J. Houldsworth, L. Cahill, M. Schiffman +6 more
2013Gynecologic Oncology25 citations Open access
Semantic Scholar
HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease
P. Luhn, N. Wentzensen
2013Current Obstetrics and Gynecology Reports22 citations Open access
Semantic Scholar
Association of systemic corticosteroids with overall survival in patients receiving cancer immunotherapy for advanced melanoma, non-small cell lung cancer or urothelial cancer in routine clinical practice
A. Drakaki, P. Luhn, H. Wakelee, P. Dhillon +7 more
2019Annals of Oncology20 citations Open access
Semantic Scholar
Disparities in Tumor Mutational Burden, Immunotherapy Use, and Outcomes Based on Genomic Ancestry in Non–Small-Cell Lung Cancer
O. Brawley, P. Luhn, Deonna Reese-White, U. Ogbu +6 more
2021JCO Global Oncology17 citations Open access
Semantic Scholar
Comparative effectiveness of first-line nab-paclitaxel versus paclitaxel monotherapy in triple-negative breast cancer.
P. Luhn, S. Chui, A. Hsieh, J. Yi +6 more
2019Journal of Comparative Effectiveness Research12 citations
Semantic Scholar
Identification of FAKTS as a novel 14‐3‐3‐associated nuclear protein
P. Luhn, Haining Wang, Adam I. Marcus, H. Fu
2007Proteins: Structure, Function, and Bioinformatics12 citations
Semantic Scholar
Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer in a Real-World Database
S. Huepenbecker, J. Wright, M. K. Downer, D. Incerti +6 more
2022Obstetrics and Gynecology10 citations Open access
Semantic Scholar
Patterns and adoption of BRCA testing in ovarian cancer in the real world: Observations from Flatiron Health
L. Meyer, J. Wright, M. K. Downer, D. Incerti +5 more
20203 citations
Semantic Scholar
Real World Treatment Patterns Of Patients With Ovarian Cancer Receiving First Line Chemotherapy In The United States
N. Yu, Y. Xiao, J. Yi, D. Oliveri +2 more
20173 citations Open access
Semantic Scholar
Endocrine therapy resistance (ETR) in hormone receptor-positive, HER2-negative metastatic breast cancer (HR+, HER2– mBC): Prevalence, biomarker characteristics, and outcomes.
R. Jeselsohn, Lu Chen, Nayan Chaudhary, J. Martinalbo +7 more
2023Journal of Clinical Oncology2 citations
Semantic Scholar
Abstract PS10-20: Neoadjuvant (neoadj) and adjuvant (adj) treatment patterns in HER2-positive early breast cancer (EBC): Analysis of US real-world oncology data
P. Dhillon, C. Flores, T. Sanglier, V. Antao +5 more
20212 citations
Semantic Scholar
Abstract P5-11-07: Real-world predictors of first-line treatment and descriptive outcomes in HR+/HER2−metastatic breast cancer patients in the US
M. K. Downer, K. Jhaveri, A. Bardia, S. Loi +3 more
2020Poster Session Abstracts2 citations
Semantic Scholar
Health disparities around the world: perspectives from the 2012 Principles and Practice of Cancer Prevention and Control course at the National Cancer Institute.
Neetu Chawla, D. Kepka, B. Heckman-Stoddard, Hisani N. Horne +5 more
2013Journal of Oncology Practice2 citations Open access
Semantic Scholar
EVOLUTION OF THE OVERALL SURVIVAL OF PATIENTS WITH ABC FROM 2011 TO 2025: AN ANALYSIS OF ELECTRONIC HEALTH RECORDS IN THE US
T. Sanglier, Janine Hoffart, P. Lambert, J. Mouta +3 more
2025Breast1 citations Open access
Semantic Scholar
Abstract 437: Comprehensive genomic profiling (CGP) in breast cancer (BC): Patterns and results from a clinico-genomic database
A. Rody, Nayan Chaudhary, C. Craggs, M. Debiasi +6 more
2021Clinical research1 citations
Semantic Scholar
Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice
J. O'Shaughnessy, L. Emens, S. Chui, Wei Wang +5 more
2021Current Oncology1 citations Open access
Semantic Scholar
Abstract 29: Utility of novel clinico-genomic data to understand patient characteristics, treatments, and outcomes according to PIK3CA mutation status among hormone receptor-positive metastatic breast cancer patients
M. K. Downer, P. Lambert, S. Mahrus, K. Hutchinson +2 more
2020Poster Presentations - Proffered Abstracts1 citations
Semantic Scholar
Abstract P4-13-08: Time to treatment discontinuation of second-line fulvestrant monotherapy for HR+/HER2− metastatic breast cancer in the real-world setting
P. Luhn, C. O'Hear, T. Ton, T. Sanglier +5 more
2019Poster Session Abstracts1 citations
Semantic Scholar
Patterns and predictors of first-line (1L) taxane use in US patients with metastatic triple-negative breast cancer (mTNBC)
J. O'Shaughnessy, L. Emens, S. Chui, K. Russell +4 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
RWD154 EXTERNAL CONTROL ARM FEASIBILITY ACROSS EXTERNAL DATA SOURCES IN ONCOLOGY: METHODOLOGICAL AND REGULATORY SCIENCE CONSIDERATIONS
Bernat Navarro, Kawther Abdilleh, A. Alabaster, P. Ansell +14 more
2026Value in Health0 citations
Semantic Scholar
Abstract PS5-01-10: Estimating the effect of initiating early maintenance endocrine therapy on brain metastases-free survival and other clinical outcomes in patients with HER2+/HR+ mBC without brain metastases: A target trial emulation
T. Sanglier, I. Gravestock, J. Leone, M. Secrest +12 more
2026Clinical Cancer Research0 citations
Semantic Scholar
Abstract PS7-23: Neoadjuvant and adjuvant therapy (NAT/AT) treatment patterns and clinical characteristics in a real-world cohort of US patients with HR+/HER2− early breast cancer (eBC)
M. K. Downer, C. Craggs, P. Dhillon, P. Luhn +5 more
20210 citations
Semantic Scholar
Abstract D088: Analysis of tumor mutational burden, cancer immunotherapy use and outcomes based on genomic ancestry in non-small cell lung cancer patients treated in community practice in the United States
N. Richie, P. Luhn, U. Ogbu, Gerren Wilson +3 more
20200 citations
Semantic Scholar
Abstract P2-15-09: Systemic corticosteroid use in patients with metastatic triple-negative breast cancer treated with first-line therapy in the United States
M. K. Downer, P. Luhn, D. Miles, M. Kent +2 more
20200 citations
Semantic Scholar
Uptake of targeted therapy in clinical practice among US patients with ovarian cancer.
J. Chan, L. Meyer, P. Luhn, C. Flores +4 more
20200 citations
Semantic Scholar
12-month uptake of PD-L1 testing and atezolizumab (atezo) + nab-paclitaxel (nab-pac) treatment in metastatic triple-negative breast cancer (mTNBC) following accelerated FDA-approval in the United States.
L. Emens, C. Craggs, M. Debiasi, M. Kent +2 more
20200 citations
Semantic Scholar
Abstract 6323: Identification of genomic alterations related to treatment progression in RWD
Nayan Chaudhary, P. Luhn, G. Jansen, C. Metcalfe +1 more
2020Experimental and Molecular Therapeutics0 citations
Semantic Scholar
Abstract 5388: Association of baseline systemic corticosteroid use with time to next treatment in patients with advanced melanoma, non-small cell lung cancer or urothelial cancer receiving cancer immunotherapy in US clinical practice
A. Drakaki, P. Dhillon, H. Wakelee, S. Chui +7 more
2020Clinical research0 citations
Semantic Scholar
195P Neoadjuvant chemotherapy (NACT) use and response in US patients with early-stage triple-negative breast cancer in the National Cancer Database (NCDB)
M. Kashyap, M. K. Downer, M. Debiasi, K. Russell +3 more
20200 citations Open access
Semantic Scholar
Abstract P1-14-04: Outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated in second line (2L) in the US real-world setting
P. Luhn, C. O'Hear, T. Ton, A. Hsieh +4 more
2019Poster Session Abstracts0 citations
Semantic Scholar
Overall survival of elderly metastatic colorectal cancer patients treated in second and third line by tumor site.
P. Luhn, E. Cha, A. Hsieh, M. Taylor +1 more
20170 citations
Semantic Scholar
Abstract 3477: Discovery and validation of methylation markers for early detection of endometrial cancer.
N. Wentzensen, Jamie N. Bakkum, K. Killian, V. Shridhar +10 more
20130 citations
Semantic Scholar
Abstract 4475: Association of endometrial cancer risk factors and DNA methylation in benign endometrial tissue
P. Luhn, M. Sherman, K. Killian, Lisa G. Adams +6 more
20120 citations
Semantic Scholar
Abstract 5012: DNA methylation profiles of endometrial cancer and benign endometrium suggest differences by mismatch repair status and possible early detection markers
N. Wentzensen, K. Killian, Lisa G. Adams, P. Luhn +10 more
20120 citations
Semantic Scholar
Enhancing a Cancer Prevention and Control Curriculum through Interactive Group Discussions
L. Forsythe, S. Gadalla, J. Hamilton, B. Heckman-Stoddard +5 more
2012Journal of Cancer Education0 citations Open access
Semantic Scholar
Human papillomavirus and cervical cancer.
P. Luhn, N. Wentzensen
1988The Lancet0 citations
Semantic Scholar
Thesauri : Introduction and Recent Developments
P. Luhn
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Wentzensen×8
Invite
N. Wentzensen — researcher profile on SciRah
M. K. Downer×8
Invite
M. K. Downer — researcher profile on SciRah
S. Chui×6
Invite
S. Chui — researcher profile on SciRah
M. Kent×6
Invite
M. Kent — researcher profile on SciRah

×5

Invite

R. Guido — researcher profile on SciRah

Lori d’Ambrosio×5

Invite

Lori d’Ambrosio — researcher profile on SciRah

Invite

P. Dhillon — researcher profile on SciRah

N. Wentzensen×4

Invite

N. Wentzensen — researcher profile on SciRah

Lisa G. Adams×4

Invite

Lisa G. Adams — researcher profile on SciRah

Hannah P. Yang×4

Invite

Hannah P. Yang — researcher profile on SciRah

Invite

M. Sherman — researcher profile on SciRah

Nayan Chaudhary×4

Invite

Nayan Chaudhary — researcher profile on SciRah